Specification

















IARC Monographs on the Evaluation of Carcinogenic Risks to Humans:

!;'*:*
 "$$$;E?$6((8(,;'
,6$?7
 "$$$;E?$6((8(,;'
-6**,6
/,,(*$$
"$$$;#($@?$((8(6,;'"$$
$;5(8(,;'
!$(
 "$$$;#($@?$((8(6,;'"$$
$;E?$6((8(,;'


US. National Toxicology Program (NTP) Report on Carcinogens:
-6**,6
/,,(*$$

&!+-;'5(8
US. OSHA Specifically Regulated Substances (29 CFR 1910.1001-1050):
E$66$(,$*
 
5(
Germ Cell Mutagenicity

In vitro
Product:
#*$?$

In vivo
Product:
#*$?$
Reproductive toxicity
Product:
6*'8@$6,;?(,$*

Specific Target Organ Toxicity - Single Exposure
Product:
#*$?$


Specific Target Organ Toxicity - Repeated Exposure
Product:
#*$?$


Aspiration Hazard
Product:
#*$?$
Other effects:
#*$?$


